Abstract
In 1995, clinical guidelines for the diagnosis and treatment of patients with immunoglobulin A (IgA) nephropathy in Japan were published by a joint committee of the Special Study Group on Progressive Glomerular Disease, Ministry of Health and Welfare of Japan (Chairman, Kiyoshi Kurokawa, MD), and the Japanese Society of Nephrology (President, Toshihiko Nagasawa, MD).1 The purpose of this new committee of the Special Study Group on Progressive Glomerular Disease, Ministry of Health and Welfare of Japan (Chairman, Hideto Sakai, MD), is to provide new clinical guidelines for the diagnosis and treatment of patients with IgA nephropathy in Japan. Although this document addresses current clinical practice in Japan, it is hoped that this English version will be helpful to the international community and will facilitate further discussion on this increasingly important disease.
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Corresponding author
About this article
Cite this article
Tomino, Y., Sakai, H. & Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 7, 93–97 (2003). https://doi.org/10.1007/s10157-003-0232-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10157-003-0232-4